Akanda Corporation - Pangali Forward P/E AKAN

Logo korporat perusahaan Akanda Corporation (AKAN)

Akanda faces severe pressure from oversupply and stringent industry regulations. High dependence on a single product and the pace of legalization in Europe create significant risks. However, streamlined cross-border delivery of licensed pharmaceuticals supports high profitability. The company's forward P/E ratio reflects market expectations, where the value 0.00 expresses the state of the metric on this chart.

Pangali mangsa ngarep rega marang bathi: Akanda Corp. (AKAN) kanggo 28.04.2023 - 12.11.2026

Rincian analitis perusahaan Akanda

- kuotasi lan prakiraan analis:
Rega saham Akanda Corp.|AKAN - Bagan tingkat prakiraan
- rincian nilai pasar emiten:
Kapitalisasi pasar Akanda Corp|AKAN - Nilai Perusahaan
- informasi kapitalisasi buku:
Aset Bersih saben Siji Saham Akanda|AKAN - Nilai Akuntansi Perusahaan|Rasio Nilai Pasar marang Nilai Buku akandacorp.com|AKAN - Gunggung Aset Perusahaan
- data liabilitas lan likuiditas perusahaan:
Total Utang marang Modal Akanda|AKAN - Utang jangka dawa marang modal|Utang jangka cendhak marang ekuitas Akanda|AKAN - Gunggung utang perusahaan|Utang-utang marang kapitalisasi buku Akanda Corp|AKAN - Utang jangka dawa perusahaan|Utang jangka cendhak perusahaan Akanda|Rasio cepet akandacorp.com
- indikator profitabilitas perusahaan lan kelipatan valuasi:
AKAN - Bathi perusahaan|Proyeksi bathi mangsa ngarep Akanda|AKAN - Pangali P/E|Pangali Forward P/E Akanda Corporation|AKAN - Pangali PEG|Nilai perusahaan marang bathi sadurunge bunga, pajeg, lan panyusutan Akanda Corp|AKAN - Bathi operasional EBITDA|Bathi resik saben saham (EPS TTM) Akanda|AKAN - Bathi resik saben saham (EPS TTM)|Wutah bathi saben saham taun-ka-taun sajrone rolas wulan pungkasan akandacorp.com|AKAN - Wutah bathi saben saham ing taun iki|Prakiraan wutah bathi resik saben saham kanggo taun ngarep Akanda
Analisis komprehensif perusahaan:Akanda Corp.
Produk merek Akanda

Forward P/E is calculated as the ratio of current market capitalization to projected net income, allowing for an assessment of business value relative to expected returns. This metric helps identify value traps by weighing the modernization of Akanda (AKAN) greenhouse complexes against real profit growth potential, making the company's forward P/E a tool for distinguishing a fundamental reversal from speculative growth.

Analisis perusahaan pesaing

Pangali Forward P/E INDV|COLL: Rasio rega marang bathi sing dikarepake|Pangali Forward P/E CRON (Cronos)|Pangali Forward P/E Canopy Growth Corp. CGC|HITI - Rega marang bathi mangsa ngarep|Pangali mangsa ngarep rega marang bathi ACB (Aurora Cannabis)|Achieve Life Sciences, Inc. (ACHV) - Rega marang bathi mangsa ngarep|Prakiraan rega marang bathi Skye Bioscience Inc.|ANEB (Anebulo) - Pangali Forward P/E|Pangali Forward P/E Canndoc|Rega marang bathi mangsa ngarep Nutriband Inc. (NTRB)|Pangali Forward P/E nasuspharma.com (NSRX)|Pangali Forward P/E IGC (IGC Pharma)|Pangali Forward P/E MIRA Pharmaceuticals Inc. MIRA|FLGC - Rega marang bathi mangsa ngarep|IMCC (IM Cannabis Corp.) - Rasio rega marang bathi mangsa ngarep|ADIL: Pangali Forward P/E|Rasio rega marang bathi mangsa ngarep ARTL|ENSC (Ensysce Biosciences Inc.) - Pangali Forward P/E|Pangali Forward P/E Titan Pharma|Pangali Forward P/E GNLN|Pangali Forward P/E InMed (INM)|Rega marang bathi mangsa ngarep Enveric Biosciences ENVB|Pangali Forward P/E Bright Green Corp. BGXX|Hempacco Co., Inc. - Pangali Forward P/E